albiomin 20 %
kamada ltd, israel - plasma protein fraction - solution for infusion - plasma protein fraction 200 mg/ml - protein c - protein c - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendation.
menactra® solution for injection
sanofi-aventis singapore pte. ltd. - diphtheria toxoid protein; meningococcal (serogroup a) polysaccharide (monovalent conjugate); meningococcal (serogroup c) polysaccharide (monovalent conjugate); meningococcal (serogroup w-135) polysaccharide (monovalent conjugate); meningococcal (serogroup y) polysaccharide (monovalent conjugate) - injection, solution - 48 microgram (diptheria toxoid quantity is approximate and dependent on the conjugate polysaccharide to protein ratio) - diphtheria toxoid protein 48 mcg/dose (0.5 ml) (diphtheria toxoid quantity is approximate and dependent on the conjugate polysaccharide to protein ratio); meningococcal (serogroup a) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup c) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup w-135) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml); meningococcal (serogroup y) polysaccharide (monovalent conjugate) 4 mcg/dose (0.5 ml)
human albumin baxalta 50 g/l solution for infusion
baxalta innovations gmbh - plasma protein containing at least 95% human albumin - solution for infusion - 50 gram(s)/litre - blood substitutes and plasma protein fractions; albumin - plasma substitutes and plasma protein fractions - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.
human albumin baxalta 200 g/l solution for infusion
baxalta innovations gmbh - plasma protein containing at least 95% human albumin - solution for infusion - 200 gram(s)/litre - blood substitutes and plasma protein fractions; albumin - plasma substitutes and plasma protein fractions - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate
flexbumin 200 g/l solution for infusion
baxalta innovations gmbh - human plasma protein - solution for infusion - 200 gram(s)/litre - blood substitutes and plasma protein fractions; albumin - plasma substitutes and plasma protein fractions - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.
heamocare plus 20 mg(400 mg iron protein succinylate) + 2.5 mg chewable tablet
one pharma co., inc; distributor: one pharma co., inc - iron (as protein succinylate) , folic acid - chewable tablet - 20 mg(400 mg iron protein succinylate) + 2.5 mg
heamocare 40 mg (equivqlent to 800 mg iron protein succinylate)/ 15 ml syrup
one pharma co., inc; distributor: one pharma co., inc - iron (as protein succinylate) - syrup - 40 mg (equivqlent to 800 mg iron protein succinylate)/ 15 ml
plasma protein fraction (human) protenate liquid
hyland, division of baxter healthcare corporation - plasma protein fraction (human) - liquid - 5g - plasma protein fraction (human) 5g - blood derivatives
pharmalgen wasp venom protein powder for solution
alk-abello a/s - polistes spp venom protein extract - powder for solution - 120mcg - polistes spp venom protein extract 120mcg - allergenic extracts
pharmalgen yellow jacket venom protein powder for solution
alk-abello a/s - vespula spp venom protein extract - powder for solution - 120mcg - vespula spp venom protein extract 120mcg - allergenic extracts